Abstract
Using various chromatography methods, five steroids and two brominated lipids (1-7), 3β- hydroxy-5-cholenic acid methyl ester, stigmasta-5,24(28)-dien-3β,29-diol, 24-methylenecholest-4-en- 3β,6β-diol, cholest-5-en-3β,7β-diol, 24-vinylcholest-5-en-3β,24-diol, xestospongiene A, and xestospongiene J, respectively, were isolated from the methanol extract of Vietnamese marine sponge Haliclona oculata (Linnaeus, 1759). Their structures were elucidated by 1D-, 2D-NMR, and ESI-MS spectra and in comparison with those reported in the literature. Compounds 1-4, 6, and 7 were reported from Chalinidae family for the first time. In addition, all compounds were evaluated for eight human cancer cell lines as HepG-2, KB, LU-1, MCF-7, LNCaP, HL- 60, SK-Mel2, and PC-3. As shown in results, compound 2 showed significant cytotoxic activities on KB and LU-1 cancer cell lines with the IC50 values ranging from 8.74 to 9.32 μM.
Keywords: Brominated lipid, cytotoxic, Haliclona oculata, steroid.
Letters in Organic Chemistry
Title:Cytotoxic Constituents from Vietnamese Marine Sponge Haliclona oculata (Linnaeus, 1759)
Volume: 12 Issue: 10
Author(s): Phan Van Kiem, Nguyen Thi Viet Thanh, Dan Thi Thuy Hang, Nguyen Thi Cuc, Nguyen Xuan Nhiem, Pham Hai Yen, Hoang Le Tuan Anh, Bui Huu Tai, Do Thi Thao and Chau Van Minh
Affiliation:
Keywords: Brominated lipid, cytotoxic, Haliclona oculata, steroid.
Abstract: Using various chromatography methods, five steroids and two brominated lipids (1-7), 3β- hydroxy-5-cholenic acid methyl ester, stigmasta-5,24(28)-dien-3β,29-diol, 24-methylenecholest-4-en- 3β,6β-diol, cholest-5-en-3β,7β-diol, 24-vinylcholest-5-en-3β,24-diol, xestospongiene A, and xestospongiene J, respectively, were isolated from the methanol extract of Vietnamese marine sponge Haliclona oculata (Linnaeus, 1759). Their structures were elucidated by 1D-, 2D-NMR, and ESI-MS spectra and in comparison with those reported in the literature. Compounds 1-4, 6, and 7 were reported from Chalinidae family for the first time. In addition, all compounds were evaluated for eight human cancer cell lines as HepG-2, KB, LU-1, MCF-7, LNCaP, HL- 60, SK-Mel2, and PC-3. As shown in results, compound 2 showed significant cytotoxic activities on KB and LU-1 cancer cell lines with the IC50 values ranging from 8.74 to 9.32 μM.
Export Options
About this article
Cite this article as:
Kiem Van Phan, Thanh Thi Viet Nguyen, Hang Thi Thuy Dan, Cuc Thi Nguyen, Nhiem Xuan Nguyen, Yen Hai Pham, Anh Le Tuan Hoang, Tai Huu Bui, Thao Thi Do and Minh Van Chau, Cytotoxic Constituents from Vietnamese Marine Sponge Haliclona oculata (Linnaeus, 1759), Letters in Organic Chemistry 2015; 12 (10) . https://dx.doi.org/10.2174/1570178612999150923120855
DOI https://dx.doi.org/10.2174/1570178612999150923120855 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hyaluronan and Hyaluronan Synthases: Potential Therapeutic Targets in Cancer
Current Drug Targets - Cardiovascular & Hematological Disorders Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Antioxidant Effects and in vitro Cytotoxicity on Human Cancer Cell Lines of Flavonoid-Rich Flamboyant (<i>Delonix regia</i> (Bojer) Raf.) Flower Extract
Current Pharmaceutical Biotechnology Neuroimaging Features of Acquired Metabolic and Toxic Encephalopathies
Current Medical Imaging Current Management of In Situ and Invasive Cervical Adenocarcinoma
Current Women`s Health Reviews LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers
Current Cancer Drug Targets CDK9: Therapeutic Perspective in HCC Therapy
Current Cancer Drug Targets Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
Current Pharmaceutical Biotechnology Biotechnological Production of Taxol and Related Taxoids: Current State and Prospects
Anti-Cancer Agents in Medicinal Chemistry Personalized Diabetes and Cancer Medicine: A Rationale for Anti-Diabetic Nutrition (Bitter Melon) in a Supportive Setting
Current Cancer Therapy Reviews Channel-Like Functions of the 18-kDa Translocator Protein (TSPO): Regulation of Apoptosis and Steroidogenesis as Part of the Host-Defense Response
Current Pharmaceutical Design Muscular Gene Transfer Using Nonviral Vectors
Current Gene Therapy Promotion of Metastasis-associated Gene Expression in Survived PANC-1 Cells Following Trichostatin A Treatment
Anti-Cancer Agents in Medicinal Chemistry Synthesis, Biological and Computational Evaluation of Novel Oxindole Derivatives as Inhibitors of Src Family Kinases
Letters in Drug Design & Discovery Synthesis, Characterization and In Vitro Antiproliferative Effects of Novel 5-Amino Pyrazole Derivatives against Breast Cancer Cell Lines
Recent Patents on Anti-Cancer Drug Discovery Anticancer Mechanisms of Bioactive Peptides
Protein & Peptide Letters Emerging Strategies and Challenges for Controlled Delivery of Taxanes: A Comprehensive Review
Current Drug Metabolism Enhancing Oral Bioavailability of Methylnaltrexone Using an Emulsion Formulation
Letters in Drug Design & Discovery Methods to Access 2-aminobenzimidazoles of Medicinal Importance
Current Organic Chemistry Disorders of Innate Immunity in Human ageing and effects of Nutraceutical Administration
Endocrine, Metabolic & Immune Disorders - Drug Targets